Literature DB >> 2127826

Erythropoietin deficiency in acute renal failure.

G W Lipkin1, R G Kendall, L J Russon, J H Turney, D R Norfolk, A M Brownjohn.   

Abstract

Erythropoietin (Epo) was sequentially measured by radioimmunoassay in 11 patients with acute renal failure (ARF) of varied aetiology. Epo rapidly decreased to a level inappropriately low for the haemoglobin, the reduced Epo value persisting throughout the oliguric phase and for up to 2 weeks after the restoration of apparently normal renal function. Epo values found in ARF were: at referral 18.2 +/- 9.5, mid-oliguria 14.4 +/- 6.8, diuresis 15.6 +/- 5.8, and recovery 25.1 +/- 15.8 mU/ml. Results are compared with 34 patients with end-stage chronic renal failure, 42 with non-renal anaemia, and 96 normal subjects. Epo deficiency alone is an inadequate explanation of the rapid reduction in haemoglobin at the onset of ARF, but would appear to be an important factor in the maintenance of anaemia in prolonged ARF and accounts for the slow increase in haemoglobin following recovery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127826     DOI: 10.1093/ndt/5.11.920

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis.

Authors:  Lindsay M Coe; Sangeetha Vadakke Madathil; Carla Casu; Beate Lanske; Stefano Rivella; Despina Sitara
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

2.  Klotho deficiency disrupts hematopoietic stem cell development and erythropoiesis.

Authors:  Sangeetha Vadakke Madathil; Lindsay M Coe; Carla Casu; Despina Sitara
Journal:  Am J Pathol       Date:  2014-01-08       Impact factor: 4.307

3.  Erythropoietin in patients with acute renal failure and continuous veno-venous haemofiltration.

Authors:  S Morgera; P Heering; T Szentandrasi; C Niederau; B Grabensee
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Erythropoietin in thrombotic thrombocytopenic purpura and acute renal failure.

Authors:  S Heidenreich; K H Rahn; W Zidek
Journal:  Clin Investig       Date:  1992-02

5.  Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.

Authors:  Rafiou Agoro; Anna Montagna; Regina Goetz; Onyedikachi Aligbe; Gurinder Singh; Lindsay M Coe; Moosa Mohammadi; Stefano Rivella; Despina Sitara
Journal:  FASEB J       Date:  2018-02-26       Impact factor: 5.191

6.  Plasma parathyroid hormone and erythropoietin levels in patients with noninflammatory acute renal failure.

Authors:  F Kokot; A Wiecek; W Grzeszczak
Journal:  Int Urol Nephrol       Date:  1993       Impact factor: 2.370

7.  Serum soluble-Fas is a predictor of red blood cell transfusion in critically ill patients.

Authors:  Ilana Levy Korkes; Gustavo Schvartsman; Ilson Jorge Lizuka; Beata Marie Quinto; Maria Aparecida Dalboni; Maria Eugênia Canziani; Sergio Antonio Draibe; Virgilio Gonçalves Pereira; Bento Fortunato Cardoso Dos Santos; Julio Cesar Martins Monte; Marcelino de Souza Durão Junior; Marcelo Costa Batista; Oscar Fernando Pavão Dos Santos; Miguel Angelo de Góes Junior; Miguel Cendoroglo Neto
Journal:  Einstein (Sao Paulo)       Date:  2013-12

8.  Human CD133+ Renal Progenitor Cells Induce Erythropoietin Production and Limit Fibrosis After Acute Tubular Injury.

Authors:  Shikhar Aggarwal; Cristina Grange; Corinne Iampietro; Giovanni Camussi; Benedetta Bussolati
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

9.  Administration of α-Klotho Does Not Rescue Renal Anemia in Mice.

Authors:  Min Young Park; Carole Le Henaff; Despina Sitara
Journal:  Front Pediatr       Date:  2022-06-23       Impact factor: 3.569

10.  Erythropoietin mimics the acute phase response in critical illness.

Authors:  John Michael Elliot; Tanit Virankabutra; Stephen Jones; Surasak Tanudsintum; Graham Lipkin; Susan Todd; Julian Bion
Journal:  Crit Care       Date:  2003-04-24       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.